Analyses of real world data from US adults with Lp(a) test results have confirmed links between elevated levels and mitral valve disorders and supported previous studies that failed to show a link with atrial fibrillation (AF).1,2
AstraZeneca has provided a sponsorship grant towards this independent programme.